scholarly article | Q13442814 |
P356 | DOI | 10.1016/0006-8993(90)90948-B |
P698 | PubMed publication ID | 2143961 |
P2093 | author name string | Tura B | |
Tura SM | |||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 19-22 | |
P577 | publication date | 1990-06-01 | |
P1433 | published in | Brain Research | Q4955782 |
P1476 | title | The analgesic effect of tricyclic antidepressants | |
P478 | volume | 518 |
Q60682032 | 2c The antidepressant-induced analgesic effect |
Q34537259 | A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception |
Q34734580 | A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache |
Q28298267 | Advances in Perioperative Pain Management: Use of Medications with Dual Analgesic Mechanisms, Tramadol & Tapentadol |
Q38194206 | Advances in the methods for discovering novel painful bladder syndrome therapies |
Q41060545 | Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states |
Q77398161 | Analgesic effect of tianeptine in mice |
Q37056596 | Antidepressants as analgesics |
Q28352180 | Antidepressants as analgesics: an overview of central and peripheral mechanisms of action |
Q34607230 | Antidepressants in the treatment of fibromyalgia |
Q35728532 | Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release |
Q44574541 | Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites. |
Q78229120 | Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? |
Q77572724 | Effect of analgesics on audible and ultrasonic pain-induced vocalization in the rat |
Q44543540 | Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs |
Q73883924 | Effects of clomipramine and desipramine on a C-fiber reflex in rats |
Q48305028 | Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain |
Q39405923 | Efficacy of oral doxepin and piroxicam treatment for interstitial cystitis |
Q38831882 | Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD. |
Q34367115 | Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache |
Q44351893 | Fluoxetine alters mu opioid receptor expression in obese Zucker rat extrahypothalamic regions. |
Q73315801 | Hypericum triquetrifolium Turra. extract exhibits antinociceptive activity in the mouse |
Q49026203 | Increased postoperative pain scores in chronic depression patients who take antidepressants |
Q35045125 | Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac). |
Q42461849 | Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs |
Q31962157 | Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs |
Q44351219 | Interaction between the tetracyclic antidepressant mianserin HCl and opioid receptors |
Q71134160 | Interaction of opioids with antidepressant-induced antinociception |
Q37133312 | Involvement of opioid and monoaminergic pain pathways in Aegle marmelos induced analgesia in mice |
Q39456162 | Management of temporomandibular disorders: concepts and controversies |
Q34093686 | Neuropharmacology of venlafaxine |
Q43762489 | On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor |
Q33875227 | Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods |
Q44334160 | Potentiated opioid analgesia in norepinephrine transporter knock-out mice. |
Q34203459 | Role of inflammation in bladder function and interstitial cystitis |
Q35892377 | Serotonin and noradrenaline reuptake inhibitors in animal models of pain |
Q40782822 | Subdural engraftment of serotonergic neurons following spinal hemisection restores spinal serotonin, downregulates serotonin transporter, and increases BDNF tissue content in rat. |
Q59357319 | The antinociceptive effect of fluvoxamine |
Q44174001 | The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms |
Q59357285 | The antinociceptive effect of moclobemide in mice is mediated by noradrenergic pathways |
Q73652684 | The antinociceptive effect of tramadol on a model of neuropathic pain in rats |
Q44333138 | The antinociceptive effect of trazodone in mice is mediated through both mu-opioid and serotonergic mechanisms |
Q44352868 | The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms |
Q45259825 | The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats |
Q43183760 | The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds |
Q78066724 | The relationship between pupil diameter and pain by the administration of morphine and antidepressant drugs in mice |
Q74607857 | The use of amitriptyline in patients with urinary frequency and pain |
Search more.